FierceHealthcare FierceHealthIT FierceMobileHealthcare FierceHealthPayer
FierceHealthFinance FierceEMR FiercePracticeManagemtn Hospital Impact

Syndicate content

Mrsa Infections news from FierceHealthcare

News

Study: Community MRSA infection rates increasing

Hospital MRSA cases have been a big enough threat in recent years. Now, it appears that community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are on the rise in the Read more...

MRSA infections rising in childrens' ear, nose, throat

A new study has concluded that there's been a large increase in the number of methicillin-resistant staphylococcus aureus (MRSA) infections found in kids' ears, noses and throats between 2001 and Read more...

Press Releases

FDA Clears Vioguard™ Self-Sanitizing Keyboard for Use in U.S. Hospitals and Medical Clinics

First FDA cleared computer keyboard to use germicidal properties of ultraviolet light to destroy harmful viruses and bacteria SEATTLE--(BUSINESS WIRE)-- Vioguard™LLC (www.vioguard.com) today Read more >>

Arlington Medical Resources to Release Analysis of the Complicated Skin and Skin Structure Infections Market in Europe

Report Analyzes Dynamics of Product Usage, Physicians’ Treatment Patterns and Patient Population EXTON, Pa.--(BUSINESS WIRE)-- Arlington Medical Resources (AMR), a provider of premier market Read more >>

In 2020, Forest/AstraZeneca/Dainippon Sumitomo’s Teflaro and Trius Therapeutics’ Tedizolid Will Capture Nearly One-Third o

The Overall Hospital-Treated MRSA Infections Drug Market Will Increase from $656 Million in 2010 to $730 Million in 2020, According to Findings from Decision Resources BURLINGTON, Mass.--(BUSINESS Read more >>

Despite Strong Competition from Zyvox, Cubicin and Vibativ, Three-Quarters of Surveyed Infectious Disease Specialists Repo

Ninety-Two Percent of Surveyed Physicians Say That, if Available, They Would Use Torezolid to Manage Their Patients’ Infections, According to New Report from Arlington Medical Resources EXTON, Pa.--( Read more >>

bioMérieux Receives FDA Clearance for NucliSENS EasyQ® MRSA, Automated, Rapid Molecular Screening Test

Company Offers Most Comprehensive, Cost-Effective Suite of Solutions to Detect and Screen for Methicillin Resistant Staphylococcus aureus (MRSA) MARCY L’ETOILE, France--(BUSINESS WIRE)-- bioMérieux, Read more >>